ArticleWorld journal of surgical oncology2026

CDK4/6 inhibitor combined with endocrine therapy: a real-world evaluation of efficacy and safety in HR+/HER2- advanced breast cancer.

Rui Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.